Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Azzak34on May 15, 2024 2:27pm
75 Views
Post# 36041657

RE:RE:RE:As predicted. shorting away

RE:RE:RE:As predicted. shorting awayIt's not a truthful timeline. They have 4 years to get this to the market before they lose the patent. 

As far as I'm concerned they realize they can no longer wait 4 years to get something wrong and start again, those days are gone. They've been building everything to this end. De-risking without putting all eggs in one basket and risking losing everything. 

Closer to patent expiry the cheaper we become, next 12 months is everything. Deal must be done soon and this massive endorsement by a massive cancer charity, the 2nd massive charity, puts us right where we need to be. 
<< Previous
Bullboard Posts
Next >>